Advertisement

Christine M. Eischen, PhD, Receives Professorship in Cancer Research at Thomas Jefferson


Advertisement
Get Permission

Christine M. Eischen, PhD

Christine M. Eischen, PhD

Karen Knudsen, PhD

Karen Knudsen, PhD

Christine M. Eischen, PhD, Professor and Vice Chair in the Department of Cancer Biology at Thomas Jefferson University and co-leader of the Molecular Biology & Genetics Program at the Sidney Kimmel Cancer Center, was recently invested as the inaugural Herbert A. Rosenthal, MD ’56 Professor in Cancer Research.

Dr. Eischen has spent her career studying the molecular mechanisms of tumor initiation with the goal of identifying vulnerabilities in cancer cells that could lead to new therapeutic targets. She is also a National Cancer Institute–funded investigator. In 2017, she was awarded an American Association for Cancer Research–Bayer Innovation and Discovery Grant, which supports innovation and translation of ideas from basic research into novel drugs. She will use this grant to research a new targeted compound with the goal of ultimately treating cancers with a high unmet medical need.

“Dr. Eischen’s work is vital to understanding cancer at its most fundamental levels in order to work toward treatments and cures,” said Karen Knudsen, PhD, Director of the Sidney Kimmel Cancer Center and the Hilary Koprowski Professor and Chair of the Department of Cancer Biology. “I eagerly anticipate the discoveries her lab will make with the support of this professorship.” ■


Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.